Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Stopping clozapine treatment is challenging due to the risk of psychotic relapse, as well as the development of withdrawal symptoms, but currently there is no formal guidance on how to do so.
This study assessed the impact of cognitive-behavioral therapy for psychosis on young people at clinically high risk. Can it improve transition rates and psychotic symptoms?
This study measured continuity of antipsychotic treatment in individuals with early phase schizophrenia followed for up to 18 years. What risk factors were associated with interruption of treatment?
This commentary highlights the detrimental impact of stigma and discrimination on youth at clinical high risk for psychosis, stressing the importance of interventions to address this vulnerability.